review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Martina Biggioggero | Q60319740 |
Pier Luigi Meroni | Q38544871 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | antibody | Q79460 |
P304 | page(s) | A299-304 | |
P577 | publication date | 2009-11-25 | |
P1433 | published in | Autoimmunity Reviews | Q15754966 |
P1476 | title | The geoepidemiology of the antiphospholipid antibody syndrome | |
P478 | volume | 9 |
Q38692085 | 'To test or not to test', the arguments for and against thrombophilia testing in obstetrics |
Q46857664 | Anti-Saccharomyces cerevisiae antibodies in patients with systemic lupus erythematosus |
Q48020789 | Anti-mullerian hormone levels decline with the presence of antiphospholipid antibodies |
Q41737006 | Anti-phospholipid antibodies in patients undergoing total joint replacement surgery |
Q90312463 | Antiphospholipid Antibodies: From General Concepts to Its Relation with Malignancies |
Q89810829 | Antiphospholipid Antibody Testing in a General Population Sample from the USA: An Administrative Database Study |
Q90312460 | Antiphospholipid Syndrome and Kidney Involvement: New Insights |
Q41808505 | Antiphospholipid antibodies and systemic scleroderma |
Q36923241 | Antiphospholipid antibodies detected by line immunoassay differentiate among patients with antiphospholipid syndrome, with infections and asymptomatic carriers. |
Q64046338 | Antiphospholipid syndrome |
Q37228076 | Association between antiphospholipid antibodies and all-cause mortality among end-stage renal disease patients with and without SLE: a retrospective cohort study |
Q39502759 | Association between antiphospholipid antibodies and arterial thrombosis in patients with rheumatoid arthritis |
Q34024573 | Autoimmune or auto-inflammatory syndrome induced by adjuvants (ASIA): Old truths and a new syndrome? |
Q33825348 | Autoimmunity and environment: am I at risk? |
Q37212291 | Behçet's Disease, Associated Large Vessel Thrombosis, and Coexistent Thrombophilia: A Distinct Nosological Entity? |
Q37841101 | Celiac disease: a model disease for gene-environment interaction |
Q36159957 | Clinical and laboratory characteristics of children positive for antiphospholipid antibodies |
Q34659598 | Coagulopathy triggered autoimmunity: experimental antiphospholipid syndrome in factor V Leiden mice |
Q42130326 | Complete Resolution of a Large Bicuspid Aortic Valve Thrombus with Anticoagulation in Primary Antiphospholipid Syndrome. |
Q45959876 | Cutting-edge issues in organ-specific autoimmunity. |
Q92244140 | Diagnosis and Therapy Before Assisted Reproductive Treatments. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Register Number 015-085, February 2019) - Part 1, Basic Assessment of the Woman |
Q38805695 | Does APS Impact Women's Fertility? |
Q28390922 | Epidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences Expert Panel Workshop |
Q42558630 | Explosion of autoimmune diseases and the mosaic of old and novel factors |
Q45932087 | Geographical differences in autoantibodies and anti-infectious agents antibodies among healthy adults. |
Q50041259 | Immunological Rare Diseases |
Q64043321 | Infodemiology of antiphospholipid syndrome: Merging informatics and epidemiology |
Q37704874 | Isolated IgA anti- β2 glycoprotein I antibodies in patients with clinical criteria for antiphospholipid syndrome |
Q35907083 | LDLR and PCSK9 Are Associated with the Presence of Antiphospholipid Antibodies and the Development of Thrombosis in aPLA Carriers |
Q51332462 | Lupus anticoagulant: a marker for stroke and venous thrombosis in primary Sjögren's syndrome. |
Q83082263 | Mechanisms and pathophysiology of autoimmune disease |
Q39298598 | Pravastatin does not prevent antiphospholipid antibody-mediated changes in human first trimester trophoblast function. |
Q38891094 | Pregnancy Outcome in Women with Obstetric and Thrombotic Antiphospholipid Syndrome-A Retrospective Analysis and a Review of Additional Treatment in Pregnancy. |
Q40838962 | Prevalence of thrombophilic disorders in takotsubo patients: the (ThROmbophylia in TAkotsubo cardiomyopathy) TROTA study |
Q41980805 | Recurrent arterial and venous thrombosis in a 16-year-old boy in the course of primary antiphospholipid syndrome despite treatment with low-molecular-weight heparin: a case report |
Q51065284 | Reduction of annexin A5 anticoagulant ratio identifies antiphospholipid antibody-positive patients with adverse clinical outcomes. |
Q45245990 | Reproductive immunology: a focus on the role of female sex hormones and other gender-related factors |
Q26775647 | Sarcoidosis and Antiphospholipid Syndrome: A Systematic Review of Cases |
Q64951272 | Study of Antiphospholipid Antibodies in Patients with Arterial Hypertension. |
Q33394044 | Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (II): thrombocytopenia and skin manifestations |
Q84974441 | The Persistent Challenge of Lupus Nephritis |
Q38873953 | The antiphospholipid syndrome: from pathophysiology to treatment. |
Q98945626 | The clinical and laboratory manifestations profile of antiphospholipid syndrome among Saudi Arabia population: Examining the applicability of Sapporo criteria |
Q43786536 | The future of autoimmunity |
Q34402456 | The relationship between mean platelet volume and thrombosis recurrence in patients diagnosed with antiphospholipid syndrome |
Q26866133 | The role of the gut microbiota in the pathogenesis of antiphospholipid syndrome |
Q37967566 | The therapeutic potential of epigenetics in autoimmune diseases. |
Q33443797 | Thrombosis and antiphospholipid antibody syndrome during acute Q fever: A cross-sectional study |
Q38258585 | Update on the current recommendations and outcomes in pregnant women with antiphospholipid syndrome |
Q90312426 | β2GP1, Anti-β2GP1 Antibodies and Platelets: Key Players in the Antiphospholipid Syndrome |
Search more.